GlassScriptPhysician profile
Brian James Groat
NPI 1841271228
$2,027.90
in general payments reported to CMS, 2019-2025
10 companies · $316 in 2025
The $316 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.98 · 2020: $545 · 2021: $699 · 2022: $53.43 · 2023: $25.59 · 2024: $324 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $640 · Honoraria: $25.59.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $639.75 |
| Honoraria | $25.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $942.15 | 2020-2025 | Tecnis Iol, Tecnis Iol |
| Alcon Vision LLC | $300.36 | 2020-2025 | Clareon, Argos, Clareon Panoptix Pro |
| Rxsight INC | $270.15 | 2021-2024 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Biotissue Holdings INC. | $264.33 | 2024 | |
| Harrow Eye, LLC | $115.89 | 2025 | Vevye |
| Carl Zeiss Meditec USA, INC. | $43.34 | 2025 | |
| Staar Surgical Company | $36.77 | 2019 | |
| Mallinckrodt Hospital Products INC. | $26.70 | 2024 | Acthar |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.73 | 2019 | |
| New World Medical,INC. | $7.48 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Groat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.